Cracking Melanoma’s Armor: Supramolecular Dual-Strike on XPO1 and β-Catenin to Overcome Resistance

Researchers explored the resistance mechanism of XPO1-targeting therapy in melanoma and fabricate a proteinoid microsphere which could target XPO1 and β-catenin to maximize the effect of XPO1 inhibitors.